NEWSFLOW
CVS Group (#CVSG) – recent LFL sales +8%, “slightly ahead of management's expectations for the first four months”
- 2019-11-28 07:48:21
In November, previously writing on veterinary group CVS (CVSG) I concluded still a sell as the shares slid further lower to 650p. Today a “Trading Update” – and the shares currently approaching 30% lower on the back of it, heading towards 450p…
A year ago I concluded on veterinary group CVS (CVSG), house broker N+1 Singer has trimmed forecasts and its latest numbers suggest a price/earnings multiple, with the shares currently at circa 1100p, of approaching 24x. Given the reported situation, that still looks high and this looks a sell. Today another AGM update – and the shares currently more than 10% lower on the back of it… at 650p…
From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2017 and thus far in 2018 (by net short position %) - and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...
Shares in veterinary group CVS (CVSG) are currently sliding despite an AGM Statement commencing “the board is pleased to announce that in the four month period ended 31 October 2017 the group's total sales grew by 20.6% and like-for-like sales grew by 4.3% compared to the same period last year”…
Hello Share Buglers. If you have cats like me, or dogs, you’ll be painfully aware of how much vets charge these days. I’m sure they need years of training and the drugs they use don’t get any cheaper, but the price I pay for two daily tablets to keep my cat’s thyroid problem at bay is rather unnerving.